People: XOMA Corp (XOMA.OQ)
20 Apr 2018
Dr. Dee Datta is Chief Business Officer of the Company. Dr. Datta brings extensive leadership experience in business development, alternative financing strategies and corporate strategy. Prior to joining XOMA, Dr. Datta served as Vice President of Corporate Development at Forty Seven, Inc., where she managed business development, strategy and transactions, company financing and investor relations. Previously, Dr. Datta was the Senior Director of Business Development at XOMA. During her time at XOMA, she successfully closed multiple transactions, including licensing deals with Novartis and Novo Nordisk. Earlier in her career, Dr. Datta was a venture capitalist at The Column Group and Longitude Capital. As an investor, she has experience in alternative financing strategies, such as royalty monetization, in addition to formation and management of portfolio companies. Dr. Datta received her Ph.D. from California Institute of Technology and M.B.A. from Stanford University Graduate School of Business.
|Total Annual Compensation,||--|
|Restricted Stock Awards,||--|
|Long-Term Incentive Plans,||--|
|Fiscal Year Total,||--|